The Chicago Cubs' rotation has suffered a devastating blow, with promising young pitcher Cade Horton facing an extended absence. Following elbow discomfort that cut short his second start of the season, the team has confirmed the 24-year-old right-hander underwent season-ending surgery on Thursday.

The procedure, performed by renowned orthopedic surgeon Dr. Keith Meister, was extensive. Horton received a revision repair of his ulnar collateral ligament (UCL), a repair of the flexor muscle, and an internal brace procedure. Manager Craig Counsell revealed the sobering recovery timeline: 15 to 16 months, which could sideline Horton for the remainder of the 2026 season and a significant portion of 2027.

This marks a heartbreaking setback for a pitcher who has already battled back from major arm surgery. Horton previously underwent Tommy John surgery as a freshman at Oklahoma before the Cubs selected him seventh overall in the 2022 draft. His resilience was on full display during an outstanding rookie campaign last year, where he posted a 2.67 ERA, finished second in NL Rookie of the Year voting, and showcased ace potential with a dazzling 1.03 ERA in the second half.

"When something like this happens, the only thing you can do is kind of worry about what’s next," Counsell told reporters, emphasizing a day-by-day approach to Horton's lengthy rehab. For the Cubs, it's the second consecutive season a key starting pitcher has been lost to a season-ending injury, a brutal challenge for a team with postseason aspirations. The focus now shifts to Horton's grueling recovery journey and the organization's need to fill a major void on the mound.